logo

Greenwich Lifesciences, Inc. (GLSI)



Trade GLSI now with
  Date
  Headline
5/23/2022 6:05:40 AM Greenwich LifeSciences Provides Updates On Upcoming Phase III Clinical Trial & ASCO Meeting
2/1/2022 6:11:06 AM Greenwich LifeSciences Updates On Upcoming Phase III Clinical Trial, FLAMINGO-01
1/24/2022 6:21:01 AM Greenwich LifeSciences To Implement Stock Repurchase Program For Up To $10 Mln
12/9/2021 6:36:01 AM Greenwich LifeSciences Presents 5 Year Data For GP2 Phase IIb Trial, Revealing Potential For T Cell Platform Tech
9/9/2021 6:10:13 AM Berkeley Lights Appoints Siddhartha Kadia To Board Of Directors
9/9/2021 6:08:43 AM Greenwich LifeSciences Provides Updates On Developments
6/7/2021 6:33:45 AM Greenwich LifeSciences Publishes Additional Positive Safety Data From GP2 Phase IIb Trial At ASCO
4/14/2021 6:04:01 AM Greenwich LifeSciences Announces Update Of GP2 Phase III Clinical Trial Design At AACR Annual Meeting
4/12/2021 5:55:28 AM Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th At 2021 AACR Annual Meeting
4/9/2021 5:06:22 AM Greenwich LifeSciences Reports Abstract Results Of 5-yr Immune Response Data Of GP2 Phase 2b Clinical Trial At AACR